» Articles » PMID: 17496909

Differential Regulation and Properties of MAPKs

Overview
Journal Oncogene
Date 2007 May 15
PMID 17496909
Citations 618
Authors
Affiliations
Soon will be listed here.
Abstract

Mitogen-activated protein kinases (MAPKs) regulate diverse cellular programs including embryogenesis, proliferation, differentiation and apoptosis based on cues derived from the cell surface and the metabolic state and environment of the cell. In mammals, there are more than a dozen MAPK genes. The best known are the extracellular signal-regulated kinases 1 and 2 (ERK1/2), c-Jun N-terminal kinase (JNK(1-3)) and p38(alpha, beta, gamma and delta) families. ERK3, ERK5 and ERK7 are other MAPKs that have distinct regulation and functions. MAPK cascades consist of a core of three protein kinases. Despite the apparently simple architecture of this pathway, these enzymes are capable of responding to a bewildering number of stimuli to produce exquisitely specific cellular outcomes. These responses depend on the kinetics of their activation and inactivation, the subcellular localization of the kinases, the complexes in which they act, and the availability of substrates. Fine-tuning of cascade activity can occur through modulatory inputs to cascade component from the primary kinases to the scaffolding accessory proteins. Here, we describe some of the properties of the three major MAPK pathways and discuss how these properties govern pathway regulation and activity.

Citing Articles

MAPK13 phosphorylates PHGDH and promotes its degradation via chaperone-mediated autophagy during liver injury.

Xing R, Liu R, Man Y, Liu C, Zhang Y, Gao H Cell Discov. 2025; 11(1):15.

PMID: 39962071 PMC: 11832932. DOI: 10.1038/s41421-024-00758-w.


Structural and kinetic characterization of DUSP5 with a Di-phosphorylated tripeptide substrate from the ERK activation loop.

Imhoff A, Sweeney N, Bongard R, Syrlybaeva R, Gupta A, Del Carpio E Front Chem Biol. 2025; 3.

PMID: 39749114 PMC: 11694514. DOI: 10.3389/fchbi.2024.1385560.


Neutrophil diversity and function in health and disease.

Zhang F, Xia Y, Su J, Quan F, Zhou H, Li Q Signal Transduct Target Ther. 2024; 9(1):343.

PMID: 39638788 PMC: 11627463. DOI: 10.1038/s41392-024-02049-y.


Challenges in tendon-bone healing: emphasizing inflammatory modulation mechanisms and treatment.

Jiang F, Zhao H, Zhang P, Bi Y, Zhang H, Sun S Front Endocrinol (Lausanne). 2024; 15:1485876.

PMID: 39568806 PMC: 11576169. DOI: 10.3389/fendo.2024.1485876.


Genomic strategies for drug repurposing.

Dave K, Patel D, Dave N, Jain M J Egypt Natl Canc Inst. 2024; 36(1):35.

PMID: 39523244 DOI: 10.1186/s43046-024-00245-z.